Sebastien Hotte

McMaster University

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (5)

Aly-Khan A. Lalani

McMaster University

Scott Morgan

Associate Professor

University of Ottawa

Di Maria Jiang

University Health Network

Eric William

Western University

Gavin Marx

Australian National University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastien Hotte

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (5)

Aly-Khan A. Lalani

Scott Morgan

Di Maria Jiang

Eric William

Gavin Marx

Make your next move.

Sebastien Hotte

Research Interests

Explore related searches

Contact this professor

Articles (10)

Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

Genetic testing practices among specialist physicians who treat prostate cancer: A Canadian cross-sectional survey

The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey

Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel

Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada

First look at the baseline characteristics of participants in IRONMAN, the international registry for men with advanced prostate cancer.

Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).

Collaborators (5)

Aly-Khan A. Lalani

Scott Morgan

Di Maria Jiang

Eric William

Gavin Marx

Make your next move.